However, biological features of the examined primary OvCa cells, characterized by high expression of MSCs markers such as CD73 and CD105, involved in tumor progression and metastasis, can serve as a therapeutic target for specific neutralizing antibodies inhibiting ovarian cancer growth and metastasis [26,27]. The gene discussed is NT5E; the disease is ovarian cancer.